Mortality | p-value | ||
Yes | No | ||
Subjects | 18 | 290 | |
Age yrs | 79.9±8.5 | 79±9.9 | ns |
Sex male | 13 (72) | 198 (68) | ns |
Charlson index | 2.7±1.9 | 2.3±1.7 | ns |
Comorbidities | |||
COPD | 5 (28) | 92 (32) | ns |
Cancer | 3 (17) | 46 (16) | ns |
Chronic liver disease | 3 (17) | 23 (8) | ns |
Diabetes mellitus | 4 (22) | 57 (20) | ns |
Mean of FEV1 in COPD patients | 37.7±10.2 | 44.6±13.0 | ns |
ICU admission | 2 (11) | 9 (3) | ns |
CAP treated with monotherapy | 7(39) | 93 (32) | |
CAP aetiology | ns | ||
Streptococcus pneumoniae | 6 (33) | 108 (35) | |
Legionella pneumophila | 1 (6) | 7 (3) | |
Others | 1 (0) | 25 (9) | |
Unknown | 10 (55) | 155 (53) | |
Class V of PSI | 10 (56) | 87 (30) | 0.007 |
Hypotension | 1 (5) | 19 (7) | ns |
Systemic steroid treatment | 5 (7) | 65 (22) | ns |
Data are presented as n, mean±sd or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in one second; ICU: intensive care unit; PSI: prognostic severity index; ns: nonsignificant.